Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

8,377 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
[A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19].
Chen J, Liu D, Liu L, Liu P, Xu Q, Xia L, Ling Y, Huang D, Song S, Zhang D, Qian Z, Li T, Shen Y, Lu H. Chen J, et al. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 May 25;49(2):215-219. doi: 10.3785/j.issn.1008-9292.2020.03.03. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020. PMID: 32391667 Clinical Trial. Chinese.
CapOX as neoadjuvant chemotherapy for locally advanced operable colon cancer patients: a prospective single-arm phase II trial.
Liu F, Yang L, Wu Y, Li C, Zhao J, Keranmu A, Zheng H, Huang D, Wang L, Tong T, Xu J, Zhu J, Cai S, Xu Y. Liu F, et al. Chin J Cancer Res. 2016 Dec;28(6):589-597. doi: 10.21147/j.issn.1000-9604.2016.06.05. Chin J Cancer Res. 2016. PMID: 28174487 Free PMC article.
After radiological staging, patients were treated with at least 2 cycles of NAC consisting of 130 mg/m(2) oxaliplatin on d 1, plus 1,000 mg/m(2) capecitabine twice daily for 14 d every 3 weeks, followed by surgery, and then with the rest cycles of adjuvant chemother …
After radiological staging, patients were treated with at least 2 cycles of NAC consisting of 130 mg/m(2) oxaliplatin on d 1, plus 1, …
CapeOX perioperative chemotherapy versus postoperative chemotherapy for locally advanced resectable colon cancer: protocol for a two-period randomised controlled phase III trial.
Liu F, Tong T, Huang D, Yuan W, Li D, Lin J, Cai S, Xu Y, Chen W, Sun Y, Zhuang J. Liu F, et al. BMJ Open. 2019 Jan 29;9(1):e017637. doi: 10.1136/bmjopen-2017-017637. BMJ Open. 2019. PMID: 30700474 Free PMC article. Clinical Trial.
From day 1 to day 14, capecitabine will be taken orally every morning and evening at a dose of 1000mg/m(2)/d. The primary outcome measure is the 3-year disease free survival. ...
From day 1 to day 14, capecitabine will be taken orally every morning and evening at a dose of 1000mg/m(2)/d. The primary outcome mea …
Study protocol of a randomized phase III trial of comparing preoperative chemoradiation with preoperative chemotherapy in patients with locally advanced gastric cancer or esophagogastric junction adenocarcinoma: PREACT.
Liu X, Jin J, Cai H, Huang H, Zhao G, Zhou Y, Wu J, Du C, Long Z, Fang Y, Ma M, Li G, Zhou M, Yin J, Zhu X, Zhu J, Sheng W, Huang D, Zhu H, Zhang Z, Lu Q, Xie L, Zhang Z, Wang Y. Liu X, et al. BMC Cancer. 2019 Jun 20;19(1):606. doi: 10.1186/s12885-019-5728-8. BMC Cancer. 2019. PMID: 31221115 Free PMC article. Clinical Trial.
Phase II trial of preoperative chemoradiation plus perioperative SOX chemotherapy in patients with locally advanced gastric cancer.
Liu X, Li G, Long Z, Yin J, Zhu X, Sheng W, Huang D, Zhu H, Zhang Z, Cai H, Huang H, Zhao G, Zhou Y, Zhang Z, Wang Y. Liu X, et al. J Surg Oncol. 2018 Mar;117(4):692-698. doi: 10.1002/jso.24917. Epub 2017 Nov 30. J Surg Oncol. 2018. PMID: 29194623 Clinical Trial.
92-Gene molecular profiling in identification of cancer origin: a retrospective study in Chinese population and performance within different subgroups.
Wu F, Huang D, Wang L, Xu Q, Liu F, Ye X, Meng X, Du X. Wu F, et al. PLoS One. 2012;7(6):e39320. doi: 10.1371/journal.pone.0039320. Epub 2012 Jun 22. PLoS One. 2012. PMID: 22761762 Free PMC article.
Performance evaluation of HBsAg by Lumipulse HBsAg-HQ: The agreement with HBsAg by Architect HBsAg-QT and the effectiveness in predicting liver tissue pathological states of chronic hepatitis B patients.
Zhang Z, Ding R, Lu W, Yang Z, Wang Y, Zhou X, Huang D, Li X, Feng Y. Zhang Z, et al. Adv Clin Exp Med. 2018 Aug;27(8):1045-1054. doi: 10.17219/acem/69247. Adv Clin Exp Med. 2018. PMID: 29893514
8,377 results
Jump to page
Feedback